Fighting counterfeit medicines

We develop technologies to detect falsified and substandard medicines.

Technologies to detect falsified and substandard medicines

Our medicines and pharmaceutical products meet the highest safety, environmental and ethical standards. Beyond developing our own products responsibly, we also contribute our expertise to help solve global health challenges.  

For example, in low- and middle-income countries, Interpol estimates that up to 30% of all medicines are falsified or substandard, putting thousands of patients’ lives at risk. To support the fight against counterfeited pharmaceuticals, we fund the non-profit Global Pharma Health Fund (GPHF)’s efforts to identify counterfeits through the unique GPHF Minilab™. Developed for use in regions with under-developed infrastructure, this compact, portable lab fits into a tropics-resistant suitcase and enables counterfeit medicines to be detected quickly, easily and cost-effectively. The tests do not rely on external power sources and require only ordinary drinking water.   

PharmaChk – a new technology

Since 2018, we have partnered with Boston University to test, validate and optimize a technology designed to assess the validity of drugs, particularly antimalarials and antimicrobials, in low- and middle-income countries. Known as PharmaChk, this user-friendly, cartridge-based technology will help to ensure drug quality and possibly prevent increase in drug resistance. As a portable tool, it is intended for and adapted to medicines, authorities and organizations including pharmacies, wholesalers and health centers.